Bevacizumab as Rescue Treatment for Severe Recurrent Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia
作者： Alexandru Lupu , Carmen Stefanescu , Xavier Treton , Alain Attar , Olivier Corcos
DOI: 10.1097/MCG.0B013E3182688D49
关键词:
摘要: Hereditary hemorrhagic telangiectasia (HHT) also known as Rendu Osler syndrome is a vascular hereditary autosomal dominant disease, leading to dysfunction in the development of arteriovenous capillaries, usually resulting epistaxis, gastrointestinal (GI) bleeding, and iron deficiency anemia. It
sci-hub.se 参考文章(4)
Tom T. Karnezis, Terence M. Davidson, Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy Laryngoscope. ,vol. 122, pp. 495- 497 ,(2012) , 10.1002/LARY.22501
Prithviraj Bose, Jennifer L. Holter, George B. Selby, Bevacizumab in hereditary hemorrhagic telangiectasia. The New England Journal of Medicine. ,vol. 360, pp. 2143- 2144 ,(2009) , 10.1056/NEJMC0901421
Sophie Dupuis-Girod, Isabelle Ginon, Jean-Christophe Saurin, Denis Marion, Elsa Guillot, Evelyne Decullier, Adeline Roux, Marie-France Carette, Brigitte Gilbert-Dussardier, Pierre-Yves Hatron, Pascal Lacombe, Bernard Lorcerie, Sophie Rivière, Romain Corre, Sophie Giraud, Sabine Bailly, Gilles Paintaud, David Ternant, Pierre-Jean Valette, Henri Plauchu, Frédéric Faure, Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output JAMA. ,vol. 307, pp. 948- 955 ,(2012) , 10.1001/JAMA.2012.250
Andrew Mitchell, Leon A. Adams, Gerry MacQuillan, Jon Tibballs, Rohan vanden Driesen, Luc Delriviere, Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transplantation. ,vol. 14, pp. 210- 213 ,(2008) , 10.1002/LT.21417